OCX - OncoCyte Corp - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

OCX is currently covered by 4 analysts with an average price target of $16.55. This is a potential upside of $13.18 (391.1%) from yesterday's end of day stock price of $3.37.

OncoCyte Corp's activity chart (see below) currently has 27 price targets and 42 ratings on display. The stock rating distribution of OCX is 86.67% BUY and 13.33% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 38.17% with an average time for these price targets to be met of 58.45 days.

Highest price target for OCX is $5, Lowest price target is $4.25, average price target is $4.31.

Most recent stock forecast was given by MIKE MATSON from NEEDHAM on 13-May-2025. First documented stock forecast 24-Mar-2016.

Currently out of the existing stock ratings of OCX, 13 are a BUY (86.67%), 2 are a HOLD (13.33%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$4.25

$1.46 (52.33%)

$4.25

10 days ago
(13-May-2025)

2/11 (18.18%)

$1.48 (53.43%)

58

Buy

$5

$2.21 (79.21%)

$10

1 months 25 days ago
(28-Mar-2025)

1/5 (20%)

$1.79 (55.76%)

204

Buy

$5

$2.21 (79.21%)

$5

1 years 1 months 8 days ago
(15-Apr-2024)

0/4 (0%)

$2.47 (97.63%)

Hold

$3

$0.21 (7.53%)

$3.5

1 years 6 months 10 days ago
(13-Nov-2023)

2/5 (40%)

$0.24 (8.70%)

2

Buy

$25

$22.44 (876.56%)

$62

2 years 11 months 29 days ago
(24-May-2022)

1/2 (50%)

$5.31 (26.97%)

16

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is OCX (OncoCyte Corp) average time for price targets to be met?

On average it took 58.45 days on average for the stock forecasts to be realized with a an average price target met ratio 38.17

Which analyst has the current highest performing score on OCX (OncoCyte Corp) with a proven track record?

PAUL KNIGHT

Which analyst has the most public recommendations on OCX (OncoCyte Corp)?

Paul Knight works at KEYBANK and has 6 price targets and 4 ratings on OCX

Which analyst is the currently most bullish on OCX (OncoCyte Corp)?

Steven Mah with highest potential upside - $137.21

Which analyst is the currently most reserved on OCX (OncoCyte Corp)?

Keay Nakae with lowest potential downside - -$1.12

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?